Tryton Announces Enrollment Of First U.S. Patient In Pivotal Study Of Side Branch Stent
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first U.S. patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery disease. "The Tryton Stent System offers an innovative solution for these difficult cases. We are extremely pleased to have enrolled the first U.S. patient in this important study and we are encouraged by the overall performance of the device.
BMA Comment On BMJ Research Into The Impact Of The Quality And Outcomes Framework On The Treatment Of High Blood Pressure, UK
Commenting on research in the BMJ looking into the Quality and Outcomes Framework (QOF) and the treatment of people with high blood pressure, Dr Laurence Buckman, Chairman of the BMA's GPs Committee, said: "There is a mistaken belief that the Quality and Outcomes Framework is simply an incentive scheme, but it's much more than that. It was designed to fund work by GPs that previously wasn't being funded, to ensure that patients received uniform high-quality care no matter where they lived in the country, and, by doing that, to improve public health over the long term and help reduce health inequalities.
Third Of Atrial Fibrillation Patients Dissatisfied With Treatment
In a recent survey conducted of over 1, 200 patients with Atrial Fibrillation (AF), a potentially lethal heart rhythm disorder, 33% stated that they were not satisfied with their current treatment. Even patients whose current treatment is satisfactory frequently cite tragically-long delays in receiving a diagnosis, suitable care, and again, a referral to a heart rhythm specialist. British Olympian, Debbie Palmer-Green, 36, suffered the debilitating symptoms of AF even when she was competing for Great Britain as a short-track speed skater.